Background & Objectives

Respiratory and its associated infections are a significant cause of mortality worldwide. Many respiratory pathogens (Bacterial, Fungal and Viral) reported in literature have significantly worsened global health. Tuberculosis and recently emerged COVID-19 are the two pandemics caused by the respiratory pathogens have significantly increased the pressure over the world and researchers stand facing the ways to control these diseases.
Various comorbidities have been reported as major risk factors that increased the pathogenesis of these respiratory infections. Significant progress in development of theranostics related to the respiratory infections and other comorbidities such as chronic obstructive pulmonary disease (COPD), cerebrovascular disease, coronary heart disease, hypertension, tuberculosis, smoking, and diabetes has also been reported by the researchers. Since over centuries, the use of bioactive compounds against various diseases with special reference to respiratory infections have been visible in the literature. These natural bioactive compounds are the components of many of the current traditional medicines. A lot of research on bioactive compounds has been accumulated with reference to tuberculosis and COVID-19, which may be used for the development of novel drugs/molecules against these diseases. Apart from the respiratory illness, bioactive compounds have been also screened against various diseases such as Glaucoma, Arthritis, and Cancer etc. Therefore, the discovery and uses of these natural bioactive compounds could be exploited as newer opportunities to control these diseases in this era of antibiotic resistance and emergence of new strains of pathogens.

The Mentor

Hon’ble Sadhguru Ji
Chief Guest	Guest Of Honor	Guest Of Honor
Hon'ble, Dr. Harshvardhan Minister of Science and Technology, Minister of Health and Family Welfare and Minister of Earth Sciences, Government of India (India). Chairperson of Executive Board of WHO	Hon’ble, Shri Nitin Jairam Gadkari Minister for Road Transport & Highways and the Minister of Micro, Small and Medium Enterprises, Government of India (India).	Prof.(Mrs.) Sangeeta Shukla (Vice-Chancellor, Jiwaji University, Gwalior, M.P. India)
Patron
Prof. B. NCAMA Deputy Vice-Chancellor, UKZN, Durban, (SA)

Organizing committee Members

Chairman & Chief Organizer Dr. Dileep Tiwari Founder & C.E.O., Hericure Healthcare Ltd, 306-B, Zen Business Center, (Hinjewadi)-Wakad, Pune, (India).	President Prof. Anil A Chuturgoon, Dean Acting Dean of Research, College of Health Sciences, University of KwaZulu-Natal, Durban (South Africa)	Vice-President & Co-Organizer Prof. Janardan Kumar, Becker College, Worcester, Massachusetts USA
Advisory Board
Prof. Lilian Rose Pratt- Riccio Oswaldo Cruz Institute FIOCRUZ, Brazil	Dr. Naresh Singh Redhu Harvard Medical, Department of Immunology & Microbiology, Boston, USA .

Convener Scientific and Secretarial Committee

Working Committee

INVITED SPEAKERS

Dr. Deepa Bisht Scientist ‘E', Department of BiochemistryNational JALMA Institute for Leprosy and Other Mycobacterial Disease (ICMR), Tajganj, Agra 282004	Professor Fernando Albericio Professor, Department of Chemistry, College of Agriculture, Engineering and Science, UKZN, Durban (South Africa) & University of Barcelona (Spain)	Leonardo Jose de Moura Carvalho Professor, Oswaldo Cruz Research Laboratory of Malaria Institute in Brazil
Muktikant Ray Head, Hospital Radiopharmacy RMC, at Bhabha Atomic Research Centre, Mumbai, Inida	Professor T. S Pillay Professor of Chemical Pathology, University of Pretoria, Pretoria (South Africa)	Professor Dev Tewari Dean and Professor, Faculty of Commerce, Administration and Law, University of Zululand, (South Africa)
Dr.Savita Kulkarni Senior Scientist & professor Bhabha Atomic Research Centre | BARC · Radiation Medicine center Mumbai,India	Prof. Rajen Naidoo Academic Leader & Chief Specialist, Department of Occupational and Environmental Health, University of KwaZulu-Natal, Durban, (South Africa)	Prof. Beatriz Garcia de la Torre Department of Chemistry, College of Agriculture, Engineering and Science, UKZN, Durban, (South Africa).
Dr. Veron Ramsuran Group Leader, KwaZulu-Natal Research and Innovation Sequencing Platform (KRISP), University of KwaZulu-Natal, Durban, (South Africa).	Ms. Jigyasa Sharma Yoga Specialist, New Delhi (India)	Dr. Anil Kumar Professor & Head (Retired), Ex-Acting Vice-Chancellor, School Of Biotechnology, Devi Ahilya University, Indore, M.P. (India)
Dr Adinarayan Kunamneni Associate Consultant/Assistant Professor, Department of Medicine Mayo Clinic, Jacksoville ,Florida, USA	Dr. Dhruv Kumar, PhD Associate Professor, Amity Institute of Molecular Medicine & Stem Cell Research, Amity University U. P., Noida, (India).	Dr. Sooraj Baijnath Academic Leader: Research, PI: Catalysis and Peptide Research Unit, Discipline of Pharmaceutical Sciences, College of Health Sciences, University of KwaZulu- Natal, Durban,(South Africa)
Dr Yash Gupta Department of Infectious Diseases, Mayo Clinic Jacksoville ,Florida, USA	Dr. Sandeep Sharma Professor of Microbiology at Lovely Professional University Jalandhar, Punjab, India	Dr. Neeladri Roy Department of Chemistry, Royal College of Surgeons, Dublin, Ireland
Dr. Kamlesh Choure, Ph.D Professor & Head Department of Biotechnology AKS University, Satna (MP) India protein Inhibitor	Dr Sanjeeva Srivastava Professor, Department of Biosciences and Bioengineering INDIAN INSTITUTE OF TECHNOLOGY BOMBAY, Mumbai, India	Prof. Tulio de Oliveira Professor ,Medical Research leading global disease surveillance Genomic Surveillance Unit (Wellcome Sanger Institute) University of Oxford Stellenbosch, Western Cape, South Africa
Prof. Oliver Zishiri Senior lecturer, Department of Genetics, School of Life Sciences, University of KwaZulu-Natal, Westville Campus, Durban, South Africa	Dr. Alisa Phulukdaree University of Pretoria	Dr. Ulrich Berk (Germany) President of German Association of Homa Therapy, Germany